The great MYC escape in tumorigenesis

Slides:



Advertisements
Similar presentations
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation Silvia Di Agostino,
Advertisements

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
The Kinase-Independent, Second Life of CDK6 in Transcription
Cancer: Inappropriate Expression of Stem Cell Programs?
Charles Swanton, Julian Downward  Cancer Cell 
NF-κB: A Coordinator for Epigenetic Regulation by MLL
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Tissue Culture as a Hostile Environment: Identifying Conditions for Breast Cancer Progression Studies  Jerry W. Shay, Woodring E. Wright  Cancer Cell 
VHL Inactivation: A New Road to Senescence
Wild-Type RAS: Keeping Mutant RAS in CHK
mTOR Signaling in Melanoma: Oncogene-Induced Pseudo-Senescence?
HSF1 in Translation Cancer Cell
Mutant p53 gain of function: The NF-Y connection
Volume 14, Issue 2, Pages (August 2008)
Volume 11, Issue 4, Pages (April 2007)
A Mitochondrial Power Play in Lymphoma
RAS unplugged: Negative feedback and oncogene-induced senescence
Elodie Pronier, Ross L. Levine  Cancer Cell 
A Sweet New Role for EGFR in Cancer
Annapoorni Rangarajan, Sue J. Hong, Annie Gifford, Robert A. Weinberg 
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
Eun-Jung Jung, George A. Calin  Cancer Cell 
The Wind God Promotes Lung Cancer
Kidney Cancer: Now Available in a New Flavor
Alyson A. Lokken, Nancy J. Zeleznik-Le  Cancer Cell 
ABT-199: Taking Dead Aim at BCL-2
Volume 13, Issue 1, Pages 1-2 (January 2008)
Tissue Culture as a Hostile Environment: Identifying Conditions for Breast Cancer Progression Studies  Jerry W. Shay, Woodring E. Wright  Cancer Cell 
PICS-ure This: Prosenescence Therapy?
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Ning Li, Sergei I. Grivennikov, Michael Karin  Cancer Cell 
Raf-1 and Squamous Cell Carcinoma: Rok-ing the Boat
Volume 20, Issue 1, Pages 3-5 (July 2011)
Volume 3, Issue 4, Pages (April 2003)
Richard G. Carroll, Seamus J. Martin  Cancer Cell 
FAL1ing inside an Amplicon
Andrew J. Holland, Don W. Cleveland  Cancer Cell 
Tumor Suppression by p53: Fall of the Triumvirate?
Frances Balkwill, Kellie A. Charles, Alberto Mantovani  Cancer Cell 
A New FOXO Pathway Required for Leukemogenesis
NOTCH and PI3K-AKT Pathways Intertwined
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Volume 14, Issue 4, Pages (October 2008)
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Splicing and Dicing MYC-Mediated Synthetic Lethality
FAL1ing inside an Amplicon
Volume 10, Issue 3, Pages (September 2006)
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
The TRIP from ULF to ARF Cancer Cell
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
There's a Time and a Place for MYCN
c-Raf in KRas Mutant Cancers: A Moving Target
Ibrutinib Treatment of CLL: The Cancer Fights Back
New Myc-anisms for DNA Replication and Tumorigenesis?
Volume 12, Issue 6, Pages (December 2007)
Kidney Cancer: Now Available in a New Flavor
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
AMPK and p53 help cells through lean times
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

The great MYC escape in tumorigenesis Chi V. Dang, Kathryn A. O’Donnell, Tarja Juopperi  Cancer Cell  Volume 8, Issue 3, Pages 177-178 (September 2005) DOI: 10.1016/j.ccr.2005.08.005 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 Mechanisms for escaping MYC-induced apoptosis A: Acute or ectopic activation of Myc induces target genes involved in cell growth and cell cycle progression, but the activation of ARF, p53, and Bim (which inhibits Bcl-2) results in apoptosis or cell cycle arrest. The “AND” logic gate depicts the requirement of at least two signals, ARF-p53 AND Bim, to trigger apoptosis. B: Wild-type Myc induces lymphomagenesis coordinately with the inactivation of ARF or p53. C: Myc mutants derived from Burkitt’s lymphoma fail to activate Bim and hence promote lymphomagenesis despite the presence of wild-type p53 or ARF. Cancer Cell 2005 8, 177-178DOI: (10.1016/j.ccr.2005.08.005) Copyright © 2005 Elsevier Inc. Terms and Conditions